XTX Topco Ltd Has $226,000 Holdings in Accuray Incorporated (NASDAQ:ARAY)

XTX Topco Ltd boosted its stake in Accuray Incorporated (NASDAQ:ARAY) by 130.2% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 126,129 shares of the medical equipment provider’s stock after buying an additional 71,330 shares during the period. XTX Topco Ltd’s holdings in Accuray were worth $226,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Acuitas Investments LLC boosted its holdings in shares of Accuray by 100.4% during the 1st quarter. Acuitas Investments LLC now owns 1,420,207 shares of the medical equipment provider’s stock valued at $2,542,000 after acquiring an additional 711,654 shares in the last quarter. Mackenzie Financial Corp raised its holdings in shares of Accuray by 168.8% in the 1st quarter. Mackenzie Financial Corp now owns 733,347 shares of the medical equipment provider’s stock worth $1,313,000 after acquiring an additional 460,501 shares during the last quarter. Heartland Advisors Inc. raised its holdings in shares of Accuray by 11.8% in the first quarter. Heartland Advisors Inc. now owns 4,274,750 shares of the medical equipment provider’s stock valued at $7,652,000 after purchasing an additional 450,000 shares during the last quarter. JPMorgan Chase & Co. increased its position in shares of Accuray by 482.4% during the fourth quarter. JPMorgan Chase & Co. now owns 242,713 shares of the medical equipment provider’s stock valued at $481,000 after acquiring an additional 201,037 shares during the last quarter. Finally, Renaissance Technologies LLC increased its position in shares of Accuray by 6.8% during the 4th quarter. Renaissance Technologies LLC now owns 2,979,998 shares of the medical equipment provider’s stock valued at $5,900,000 after purchasing an additional 189,414 shares during the last quarter. Institutional investors and hedge funds own 64.08% of the company’s stock.

Accuray Stock Up 8.8%

Accuray stock opened at $1.48 on Wednesday. Accuray Incorporated has a 52 week low of $1.14 and a 52 week high of $2.95. The company has a debt-to-equity ratio of 3.35, a quick ratio of 0.92 and a current ratio of 1.64. The business has a 50-day simple moving average of $1.34 and a 200 day simple moving average of $1.64.

Analysts Set New Price Targets

Separately, Wall Street Zen raised Accuray from a “hold” rating to a “buy” rating in a research report on Friday, May 30th.

About Accuray

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.